MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.resplu.2020.100007

Медицинская библиотека · Resuscitation plus · 2020

Dose optimization of early high-dose valproic acid for neuroprotection in a swine cardiac arrest model.

Hsu Cindy H, Tiba Mohamad H, McCracken Brendan M, Colmenero Carmen I, Pickell Zachary, Leander Danielle C, Weitzel Anne M, Raghunayakula Sarita, Liao Jinhui, Jinka Tulasi, Cummings Brandon C, Pai Manjunath P, Alam Hasan B, Ward Kevin R, Sanderson Thomas H, Neumar Robert W

СтатьяПеревод в очереди

Аннотация

AIM: High-dose valproic acid (VPA) improves the survival and neurologic outcomes after asphyxial cardiac arrest (CA) in rats. We characterized the pharmacokinetics, pharmacodynamics, and safety of high-dose VPA in a swine CA model to advance clinical translation.

METHODS

After 8 ​min of untreated ventricular fibrillation CA, 20 male Yorkshire swine were resuscitated until return of spontaneous circulation (ROSC). They were block randomized to receive placebo, 75 ​mg/kg, 150 ​mg/kg, or 300 ​mg/kg VPA as 90-min intravenous infusion (n ​= ​5/group) beginning at ROSC. Animals were monitored for 2 additional hours then euthanized. Experimental operators were blinded to treatments.

RESULTS

The mean(SD) total CA duration was 14.8(1.2) minutes. 300 ​mg/kg VPA animals required more adrenaline to maintain mean arterial pressure ≥80 ​mmHg and had worse lactic acidosis. There was a strong linear correlation between plasma free VPA Cmax and brain total VPA (r2 ​= ​0.9494; p ​< ​0.0001). VPA induced dose-dependent increases in pan- and site-specific histone H3 and H4 acetylation in the brain. Plasma free VPA Cmax is a better predictor than peripheral blood mononuclear cell histone acetylation for brain H3 and H4 acetylation (r2 ​= ​0.7189 for H3K27ac, r2 ​= ​0.7189 for pan-H3ac, and r2 ​= ​0.7554 for pan-H4ac; p ​< ​0.0001).

CONCLUSIONS

Up to 150 ​mg/kg VPA can be safely tolerated as 90-min intravenous infusion in a swine CA model. High-dose VPA induced dose-dependent increases in brain histone H3 and H4 acetylation, which can be predicted by plasma free VPA Cmax as the pharmacodynamics biomarker for VPA target engagement after CA.

Для цитирования: Hsu Cindy H, Tiba Mohamad H, McCracken Brendan M, Colmenero Carmen I, Pickell Zachary, Leander Danielle C, Weitzel Anne M, Raghunayakula Sarita, Liao Jinhui, Jinka Tulasi, Cummings Brandon C, Pai Manjunath P, Alam Hasan B, Ward Kevin R, Sanderson Thomas H, Neumar Robert W. Dose optimization of early high-dose valproic acid for neuroprotection in a swine cardiac arrest model.. Resuscitation plus. 2020. DOI: 10.1016/j.resplu.2020.100007.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.